Global Virus Filtration Products Market Report 2022-2026: Expanding Biopharmaceutical Sector Generates Growth Opportunities | News

0

DUBLIN, January 14, 2022 /PRNewswire/ — The “Virus Filtering Products – Global Market Trajectory and Analysis” report has been added to ResearchAndMarkets.comit is offer.

Global virus filtration products market to reach US$6.6 billion by 2026

Amid COVID-19 crisis, Global Virus Filtration Products Market Estimated at US$3.1 billion in 2020, is expected to reach a revised size of US$6.6 billion by 2026, growing at a CAGR of 13.1% over the analysis period.

Kits & Reagents, one of the segments analyzed in the report, is expected to grow at a CAGR of 14.7% to reach US$4.9 billion at the end of the analysis period. After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the filtration systems segment is readjusted to a revised CAGR of 11% for the next 7-year period. This segment currently accounts for a 23.9% share of the global virus filtration products market.

The growth of the global market is expected to be driven by strong demand from biotechnology and biopharmaceutical industries. These industries make extensive use of virus filtration products to protect their products from any type of contamination. Other factors driving growth include favorable regulations, better funding, as well as support for various R&D projects by private companies and the government.

Increased investment and a focus on research have spurred the development of innovative technologies that facilitate the manufacture of new filtration products capable of filtering out minute structures ranging from microorganisms like viruses and bacteria to particles. The increasing use of biotherapies has stimulated R&D as well as the formulation of new drugs extracted from different natural sources for the treatment of a range of chronic disorders.

The increasing incidence of various chronic diseases and conditions around the world, combined with stringent regulations regarding virus-free treatments, is expected to propel the virus filtration industry in the medium term. The emphasis on high-tech product development, favorable government regulations, and new product launches are expected to benefit the market growth.

The US market is estimated at $1.1 billion in 2021, when China is expected to reach $899.5 million by 2026

The virus filtration products market in the United States is estimated at US$1.1 billion in 2021. The country currently accounts for a 31.98% share of the global market. China, the world’s second largest economy, is expected to reach an estimated market size of US$899.5 million in 2026 with a CAGR of 16.8% over the analysis period.

Other notable geographic markets include Japan and Canada, each predicting growth of 10.7% and 11.6% respectively over the analysis period. In Europe, Germany is expected to grow at around 12.8% CAGR while the rest of the European market (as defined in the study) will reach US$322.9 million at the end of the analysis period.

The virus filtration market is dominated by North America due to growing industrialization, patient awareness, presence of modern infrastructure, as well as high per capita healthcare expenditure. The European market is benefiting from favorable government policies on healthcare infrastructure.

Become thin Asia Pacific region is due to increased demand for high quality therapeutic products in major countries such as China and India. In developing countries like China and India, robust economic growth supports biotech and pharmaceutical units.

Segment of filtration systems to be reached $1.4 billion by 2026

A considerable portion of the growth in virus filtration comes from the biopharmaceutical sector. Amid the rise of single-use filtration products and stringent quality standards, the biopharmaceutical industry is expected to expand the membrane technology market in the near future.

In the global filtration systems segment, United States, Canada, Japan, China and Europe will drive the CAGR of 10.4% estimated for this segment. These regional markets representing a combined market size of US$570.8 million in the year 2020 will reach a projected size of US$1.1 billion at the end of the analysis period.

China will remain among the most dynamic in this group of regional markets. Led by countries such as Australia, India, and South Korea, the market for Asia Pacific should reach US$150.6 million by 2026, while Latin America will grow at a CAGR of 11.9% over the analysis period.

Main topics covered:

I. METHODOLOGY

II. ABSTRACT

1. MARKET OVERVIEW

  • Impact of Covid-19 and a looming global recession
  • Virus filtration membranes
  • A prelude to virus filtering
  • Filtration of viruses in biopharmaceuticals
  • Improved concentration of mAb
  • Impact of Covid-19 and a looming global recession
  • 2020: A year of disruption and transformation
  • As the race between the virus and vaccines heats up, where is the global economy going in 2021
  • Impact of COVID-19 on the Virus Filtration Market
  • Global Market Outlook and Prospects
  • Virus Filtration Market Poised for Rapid Growth
  • Sector analysis
  • Developed regions dominate and expand to witness fastest growth
  • Market challenges
  • Recent market activity

2. FOCUS ON CERTAIN PLAYERS (Total 41 Featured)

  • Asahi Kasei Medical Co., Ltd.
  • Charles River International Laboratories, Inc.
  • General electricity company
  • Lonza Group AG
  • Merck KgaA
  • MilliporeSigma
  • Pall Company
  • Sartorius AG
  • ThermoFisher Scientific, Inc.

3. MARKET TRENDS AND DRIVERS

  • An expanding biopharmaceutical sector generates growth opportunities
  • Pharmaceutical Industry Opens Growth Paths for Virus Filtration
  • Advanced anti-virus filters in the pharmaceutical industry
  • Technological Advancements in Filtration Drive Market Growth
  • Adsorption filtration
  • Advances in Filtration
  • Mask tracking and tracing
  • Demographic trends and growing incidence of chronic diseases to drive the market forward
  • Expansion of single-use technologies in virus filtration products
  • Virus filtration for biopharmaceutical production
  • The advent of continuous process methods is driving the growth of the market
  • Parvovirus Filtration Records Steady Growth
  • Anti-virus filters are growing rapidly
  • New air filters to fight COVID-19
  • Manufacturers show safety techniques for virus filtration

4. GLOBAL MARKET OUTLOOK

III. REGIONAL MARKET ANALYSIS

IV. COMPETETION

  • Total number of companies profiled: 41

For more information on this report, visit https://www.researchandmarkets.com/r/c8jc4g

Media Contact:

Research and Markets

Laura Wood, senior

press@researchandmarkets.com

For EST office hours, call +1-917-300-0470

For USA/CAN call toll free +1-800-526-8630

For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904

Fax (outside the US): +353-1-481-1716

Show original content:https://www.prnewswire.com/news-releases/global-virus-filtration-products-market-report-2022-2026-an-expanding-biopharmaceuticals-sector-drives-growth-opportunities-301461270.html

SOURCE Research and Markets

Share.

Comments are closed.